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Results: Our results demonstrate an isolate-dependent and
tage-dependent regulation of these genes for a new set of tested
onors, raising the interest in scaling-up the donors and parasite
solates to be tested.
Conclusion: The selected set of putative virulence-associated
enes will be used to classify ﬁeld-collected isolates according to
heir putative virulence.
(This work was supported by NIAID/NIH Grant # 5P50AI074178
nd a joint action Laboratoire International Associé of the Tunisian
inistry for Higher Education, Research and Technology/ French
entre National de Recherche Scientiﬁque).
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Background: Resistance to antimalarial drugs such as chloro-
uine, sulfadoxin-pyrimethamine has been reported from almost
ll endemic areas in the world, including Indonesia. Some stud-
es in Indonesia showed plasmodium resistance to chloroquine or
ulfadoxin-pyrimethaminewere from20% to as high as 80%. There-
ore, these drugs should be replaced by artemisinin derivatives that
urrently known as the most potent antimalarial. Artemisinin Com-
ination Therapy (ACT) has been used in Indonesia since 2004 and
ow there are three ACTs recommended by The Ministry of Health.
he aim of this study is to evaluate the efﬁcacy of artemether-
umefantrine in treating uncomplicated malaria.
Methods: This study was conducted at A. Wahab Sjahranie
eneral Hospital Samarinda, East Kalimantan, Indonesia from
anuary 2010 to December 2011. Subjects were uncomplicated
dult malaria patients treated with ﬁxed-dose combination of
0mg artemether and 120mg of lumefantrine (Coartem®) 1 tablet
very 12hours for 3 days. The variables measured were fever clear-
nce time (FCT) and parasite clearance time (PCT)
Results: During the period of 24months, therewere 47 patients
ulﬁlled the criteria of this study, consisting of 45 males (95.83%)
nd 2 females (4.17%). Age distribution was as follow: 15-24 years
0 (22.92%), 25-44 years 30 (62.50%), 45-64 years 7 (14.58%). There
ere 26 patients (56.25%) infected by P. falciparum and 21 (43.75%)
y P. vivax. MeanFCT in the group infected by P. falciparum was
6.6hours and in group infected by P. vivax was 7.1 hours. On the
hird day of treatment (D3), all subjects were free of fever. Mean
CT for P. falciparum groupwas 1.92 days and for P. vivax group 1.90
ays. On D3, 92.3% of P. falciparum group were free of parasites and
n the P. vivax group95.2%. OnD4, all patientswere free of parasites.
o patients developed into severe malaria. No signiﬁcant adverse
ffects were found in this study.
Conclusion: Artemether-lumefantrine has high efﬁcacy against
ncomplicated falciparum and vivax malaria. Adequate clinical andfectious Diseases 16S (2012) e158–e316 e161
parasitological response (ACPR) is found 92.3% for P. falciparum and
95.2% for P. vivax.
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Pulmonary embolism revealing a cardiac hydatic disease
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Background: The cardiac hydatidosis is a rare and serious
localization which can complicate of an arterial hypertension pul-
monary (PH) consequence of a secondary pulmonary embolism in
the rupture of the hydatid cysts (HC) in the right cardiac cavities or
a ﬁstulization of a hepatic HC in the inferior vena cava (IVC).
Methods: To review 2 cases reports to illustrates a unusual eti-
ology of PH
Results: Case report 1: 37 years old woman is investigated
a lung and renal syndrome mimiking ANCA vasculitis. Medical
history begins a few weeks rather with a acute dyspnoea mim-
icking embolism disease and leading to the diagnosis of a release
of pulmonary ball. The degradation of the renal function requir-
ing 9 sessions of hemodialysis which allows to get back the renal
function. An bilateral pulmonary embolism at the origin of a pul-
monary hypertension (PH) is observed in the following up. The
cardiac MRI make the diagnosis of HC localized in the right ventri-
cle complicatedwith a hydatic pulmonary embolism. Liver scanner
tomography imaging does not localizeHC at the hepatic level nor at
the level of the IVC. The patient receives a symptomatic treatment
and is transferred in thoracic and cardiac surgery.
Case report 2: 27-year-old man in the history of bilateral lung-
wort hydatidos witch was operated three years among devellops
an pulmonary embolism revealed by an acute dyspnoea and a
hemoptysis. The data of the thoracic angioscan conﬁrms an sec-
ondary bilateral massive pulmonary embolism in the rupture of a
cardiac HC of the right ventricle. So the patient beneﬁts a cardiac
surgery (cystectomy) under extracorporeal circulation. The imme-
diate course is favorable. However in 3 months of the intervention
the patient is seen again for a dyspnoea stage III of NYHAwith signs
of right-sided heart failure. The cardiac echo-Doppler ultrasound
method objectiﬁes then PA (80mm Hg of pulmonary arterial sys-
tolic pressure) and note dilatation of the right cavities. The cardiac
MRI does not objectives local recurrence.
Conclusion: PH is dramatic complication of the rupture of the
HC of the right ventricle and aggravates the prognosis of this still
